Jamie Tsung
Director, Head of DP Formulation,
Alnylam Pharmaceuticals
Joshua Ziel
Chief Operating Officer,
Aerami
Julie Zhu
Scientific Director,
GSK
Justin Cohen
Director,
Pfizer
Rachel Groppo
Director, Lead saRNA Team,
Johnson & Johnson Innovative Medicines
Robert J Duff
VP Chemistry,
Switch Therapeutics, Inc.
All Speakers
Amish Patel
VP of Technical Operations,
Calidi Biotherapeutics
Ash Dugar
Senior Vice President,
Dyne Therapeutics
Brad Niles
Chief Executive Officer,
ARIZ Precision Medicine
David Loynd
President and Chief Executive Officer,
EnduRx Pharmaceuticals Inc.
David M Jackson
Chief Executive Officer,
Ceria Therapeutics
Deepak Sampath
Senior Vice President, Head of Research,
Ultragenyx Gene Therapy
Evgenyi Shalaev
Executive Director, Pharmaceutical Development,
AbbVie
Irvin Mayers
Professor,
University of Alberta
Jacques Van Dam
VP, Medical Affairs,
Rani Therapeutics, Inc.
James Ferguson
Chief Medical Officer,
Matinas BioPharma
John Gleeson
Associate Principal Scientist,
Merck & Co.
Liang Huang
Professor,
Oregon State University
Lynn Kirkpatrick
Chief Executive Officer,
Ensysce Pharmaceuticals
Marine Hatit
Senior Scientist,
Prime Medicine
Matt Levy
VP of Exploratory Research,
Creyon Bio
Niren Murthy
Professor,
University of California, Berkeley
Paul Peng
VP, Head of CMC,
Korro Bio
Peter Petrochenko
Associate Director of Regulatory Strategy,
Regeneron
Pratik Saha
Global Head, Biopharmaceutics, Drug Product Development,
GSK
Sudip Das
Distinguished Professor,
Butler University
Vivek Gupta
Associate Dean & Associate Professor,
St. John's University
Yuchen Fan
Principal Scientist,
Genentech
Zdravka Medarova
Chief Scientific Officer,
TransCode Therapeutics, Inc.
Zhe Wu
Senior Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson